New CFO and Board Member will respectively lead the financial strategy and bring public company experience in the Company’s next chapter as it prepares to go public LEHI, Utah–(BUSINESS WIRE)–Owlet Baby Care Inc. (“Owlet” or the “Company”), the connected nursery ecosystem that delivers data-driven technology to modern parenting, is excited to […]
Other News
Endologix LLC Announces Acquisition of PQ Bypass, Inc.
Company Expands Vascular Reach to Treat Unmet Needs of Both AAA and PAD Patients IRVINE, Calif.—(BUSINESS WIRE)—April 13, 2021—Endologix LLC, a leader in the treatment of vascular disease, today announced it has completed the acquisition of PQ Bypass, Inc., a privately held medical technology company pioneering a first-of-its-kind technology that addresses […]
SentiAR Closes An Oversubscribed $5.1 Million Series A Round With TechWald Holding As A Strategic Shareholder
The financing follows FDA clearance of groundbreaking mixed reality CommandEP™ system, allowing electrophysiologists to visualize cardiac anatomy in hands-free, real-time 3D ST. LOUIS, April 13, 2021 /PRNewswire/ — SentiAR, a pioneer in visualization technology for interventional procedures, has closed an oversubscribed $5.1 million Series A financing, which will allow the company to accelerate innovation on its […]
NeoProgen, Inc. Receives First Granted Patent for Method to Treat Cardiac Conditions using Neonatal Heart-derived Medicinal Signaling Cells (nMSCs) and/or their Secretomes/Exosomes from the US Patent Office
BALTIMORE–(BUSINESS WIRE)–NeoProgen, Inc., a pre-clinical stage company developing an exosome-based product from human neonatal heart-derived Medicinal Signaling Cells (nMSCs) for tissue repair and regeneration for the treatment of heart failure (HF) and other inflammatory diseases, announced that it has received a patent from the United States Patent Office Patent No.: […]
Datos Health Announces New Partnership For Study Measuring Impact Of Digital Solutions On Heart Failure Treatment
Breakthrough Multicentered Study will Evaluate Efficacy of Digital Health Data Collection Outside the Clinic for Guideline-Directed Heart Failure Therapy NEW YORK, April 13, 2021 /PRNewswire/ — Datos Health, a leader in remote care automation, today announced its collaboration with Amgen, one of the world’s leading independent biotechnology companies, on a new study to evaluate […]
Acutus Medical Announces FDA Clearance of AcQCross™, a Full Suite of Universal Transseptal Crossing Devices
Product Family Targets Over 300,000 Annual US Electrophysiology and Structural Heart Procedures CARLSBAD, Calif., April 13, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the FDA clearance of the AcQCross™ family […]
Liquidia Corporation Announces $21.7 Million Private Placement
RESEARCH TRIANGLE PARK, N.C., April 13, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that it has entered into a common stock purchase agreement with certain institutional, accredited investors for the private placement of 8,626,037 shares of common stock at a purchase price of $2.52 per share, the […]
Amarin Announces CEO Succession Plan
John Thero to Retire as President and CEO on August 1, 2021 Board Appoints Karim Mikhail, Current SVP and Head of Commercial for Europe, as Successor DUBLIN, Ireland and BRIDGEWATER, N.J., April 12, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that John F. Thero, 60, has informed […]
Cardiac Insight Remains Committed to Serving Seniors and Medically Underserved in ECG Wearable Market
Continued focus on providing nationwide access to patients and physicians to innovative wearable ECG technologies despite updated Novitas and First Coast Reimbursement Rates and Competitive Market Exit SEATTLE–(BUSINESS WIRE)–Cardiac Insight, Inc., a healthcare innovator specializing in wearable cardiac sensors and proven automated electrocardiogram (ECG) analysis, remains committed to delivering highly […]
Cardialen Announces Positive Results from Low-Voltage MultiPulse Therapy to Terminate Atrial Fibrillation
MultiPulse Therapy™ (MPT™) achieved 71% termination of acute, induced atrial fibrillation (AF) episodes at energy levels deemed to be tolerable for patients1,2 MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., has published a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology titled Novel Low-Voltage MultiPulse Therapy to Terminate Atrial Fibrillation. The study […]
Recent
Galaxy Therapeutics Achieves CE Mark for SEAL™ Embolization System, Enabling Commercial Launch Across Europe and International Markets
Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators
Galaxy Therapeutics Achieves CE Mark for SEAL™ Embolization System, Enabling Commercial Launch Across Europe and International Markets
Popular
- No commented posts yet